Datasheet | December 9, 2024

Kardia™ 12L: Next-Generation 12-Lead ECG System

Kardia 12L

The Kardia 12L represents an innovative advancement in ECG technology, addressing traditional challenges such as lead misplacement, patient discomfort, and spatial limitations. Utilizing a simplified five-electrode system, this next-generation 12-lead ECG device can diagnose 35 cardiac conditions, including acute myocardial infarction and cardiac ischemia. Its single-cable design ensures precise and efficient data capture, allowing clinicians to prioritize patient care. Portable and battery-operated, the Kardia 12L is ideal for various research settings, offering rapid disease detection and actionable insights. FDA-cleared and validated against over 1.75 million ECG datasets, the device leverages advanced AI algorithms to deliver reliability and accuracy on par with leading ECG solutions. Designed for seamless integration into clinical trials, the Kardia 12L enhances trial efficiency with flexible data integration and straightforward site setup, significantly improving patient comfort and the overall research process.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.

Subscribe to Clinical Tech Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Tech Leader